Octreotide

insulin ; Homo sapiens







154 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33481251 Acute hyperglycaemia enhances both vascular endothelial function and cardiac and skeletal muscle microvascular function in healthy humans. 2022 Feb 2
2 34741720 Combination of pasireotide and octreotide: effects on GH and IGF-I secretion and glucose metabolism in healthy volunteers. 2022 Feb 1
3 35356161 Pasireotide use for the treatment of endogenous hyperinsulinemic hypoglycemia refractory to conventional medical therapy: A case report and review of the literature. 2022 Mar 1
4 33150747 Suppression of Insulin Secretion in the Treatment of Obesity: A Systematic Review and Meta-Analysis. 2020 Nov 2
5 31366755 [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report]. 2019 1
6 29373734 Long-Term Testosterone Administration on Insulin Sensitivity in Older Men With Low or Low-Normal Testosterone Levels. 2018 Apr 1 1
7 28592737 Octreotide LAR was useful for avoiding hypoglycemia in an elderly patient with insulinoma. 2017 2
8 28600547 Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9. 2017 Jun 9 1
9 27258938 Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans. 2016 Aug 1
10 25324442 Octreotide-associated cholestasis and hepatitis in an infant with congenital hyperinsulinism. 2015 Mar 1
11 23902932 Bed rest worsens impairments in fat and glucose metabolism in older, overweight adults. 2014 Mar 2
12 23669130 Octreotide for the treatment of hypoglycemia after insulin glargine overdose. 2013 Aug 1
13 22399695 Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. 2012 May 1
14 22408121 Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue. 2012 May 1
15 23046209 Octreotide for the treatment of sulfonylurea poisoning. 2012 Nov 1
16 21538290 Effects of long-acting release octreotide on glucose homeostasis in acromegaly patients after trans-sphenoidal surgery. 2011 Jun 2
17 21911723 Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. 2011 Oct 10 2
18 20484012 Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides. 2010 Aug 1
19 20723227 Symptomatic cerebral oedema during treatment of diabetic ketoacidosis: effect of adjuvant octreotide infusion. 2010 Aug 19 2
20 19417097 Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue. 2009 Jul 1 1
21 19625744 Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. 2009 1
22 19963157 Vinegar lacks antiglycemic action on enteral carbohydrate absorption in human subjects. 2009 Dec 1
23 17917813 Serum markers of cardiovascular risk in patients with acromegaly before and after six months of treatment with octreotide LAR. 2008 1
24 18345397 [Evaluation of glucose metabolism in acromegalic patients before and after treatment with octreotide LAR]. 2008 Feb 1
25 18353876 L-arginine-induced glomerular hyperfiltration response: the roles of insulin and ANG II. 2008 May 1
26 18630821 [New antidotes in toxicology]. 2008 Apr 30 1
27 18778119 Use of somatostatin analogues in obesity. 2008 1
28 17285009 Hypoglycemia in the intensive care unit. 2007 Mar 1
29 17339747 Deterioration of glycemic control during octreotide LAR treatment in an acromegalic Japanese patient with type 2 diabetes mellitus. 2007 Apr 1
30 16158082 A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. 2006 Feb 1
31 16423593 Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children. 2006 Jan 2
32 17185803 Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature. 2006 Aug 1
33 17229659 Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide. 2006 Nov-Dec 2
34 15649100 Pharmacologic therapies for acromegaly: a review of their effects on glucose metabolism and insulin resistance. 2005 1
35 15827099 Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome. 2005 Jul 1
36 16284426 A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide. 2005 Oct 1
37 16356235 Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. 2005 1
38 14984323 Somatostatin: beneficial effects on remission in young adult patients with newly diagnosed diabetes mellitus type 1. 2004 2
39 14988241 Discrimination between obesity and insulin resistance in the relationship with adiponectin. 2004 Mar 1
40 15279081 Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. 2004 May 1
41 15314628 Obesity, leptin resistance, and the effects of insulin reduction. 2004 Oct 1
42 12727951 Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. 2003 May 2
43 12788859 Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. 2003 Jun 3
44 12898472 Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man. 2003 Aug 1
45 14510913 Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment. 2003 Oct 1
46 14576502 Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas. 2003 Nov 1
47 14640992 Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant. 2003 Dec 1
48 11833058 Relative impact of low-density lipoprotein-cholesterol concentration and insulin resistance on carotid wall thickening in nondiabetic, normotensive volunteers. 2002 Feb 1
49 11931620 Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units. 2002 Apr 11 1
50 11932320 A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. 2002 Apr 2